GSK4527226 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-30 in 2mo
ESTIMATED |
READOUT
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's
Phase 2 · Alzheimer's Disease |
GlaxoSmithKline | GSK4527226 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|